Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

3.4.22.26: cancer procoagulant

This is an abbreviated version!
For detailed information about cancer procoagulant, go to the full flat file.

Word Map on EC 3.4.22.26

Reaction

specific cleavage of Arg-/-Ile bond in Factor X to form Factor Xa =

Synonyms

cancer procoagulant, CP

ECTree

     3 Hydrolases
         3.4 Acting on peptide bonds (peptidases)
             3.4.22 Cysteine endopeptidases
                3.4.22.26 cancer procoagulant

Reference

topprint

Reference on EC 3.4.22.26 - cancer procoagulant

Please use the Reference Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Falanga, A.; Gordon, S.G.
Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue
Biochemistry
24
5558-5567
1985
Oryctolagus cuniculus
Manually annotated by BRENDA team
Falanga, A.; Bolognese Dalessandro, A.P.; Casali, B.; Roncaglioni, M.C.; Donati, M.B.
Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics
Int. J. Cancer
39
774-777
1987
Oryctolagus cuniculus, Mus musculus
Manually annotated by BRENDA team
Falanga, A.; Shaw, E.; Donati, M.B.; Consonni, R.; Barbui, T.; Gordon, S.G.
Inhibition of cancer procoagulant by peptidyl diazomethyl ketones and peptidyl sulfonium salts
Thromb. Res.
54
389-398
1989
Oryctolagus cuniculus
Manually annotated by BRENDA team
Moore, W.R.
The purification and properties of cancer procoagulant from murine tumors
Biochem. Biophys. Res. Commun.
184
819-824
1992
Mus musculus
Manually annotated by BRENDA team
Gordon, S.G.
Cancer procoagulant
Methods Enzymol.
244
568-583
1994
Homo sapiens, Rattus norvegicus
Manually annotated by BRENDA team
Mielicki, W.P.; Kozwich, D.L.; Kramer, L.C.; Gordon, S.G.
Effect of divalent ions on the activity of cancer procoagulant
Arch. Biochem. Biophys.
314
165-170
1994
Homo sapiens
Manually annotated by BRENDA team
Mielicki, W.P.
Biochemistry of cancer procoagulant
Haemostasis
31 Suppl 1
8-10
2001
Oryctolagus cuniculus, Homo sapiens
Manually annotated by BRENDA team
Mielicki, W.P.; Mielicka, E.; Gordon, S.G.
Cancer procoagulant activity studies using synthetic peptidyl substrates
Thromb. Res.
87
251-256
1997
Homo sapiens
Manually annotated by BRENDA team
Raasi, S.; Mielicki, W.P.; Gordon, S.G.; Korte, W.
Properties of proteins in cancer procoagulant preparations that are detected by anti-tissue factor antibodies
Arch. Biochem. Biophys.
428
131-135
2004
Homo sapiens
Manually annotated by BRENDA team
Kazmierczak, M.; Lewandowski, K.; Wojtukiewicz, M.Z.; Turowiecka, Z.; Kolacz, E.; Lojko, A.; Skrzydlewska, E.; Zawilska, K.; Komarnicki, M.
Cancer procoagulant in patients with adenocarcinomas
Blood Coagul. Fibrinolysis
16
543-547
2005
Homo sapiens
Manually annotated by BRENDA team
Kamocka, M.; Rozalski, M.; Krajewska, U.; Wierzbicki, R.; Mielicki, W.P.
Effect of cancer procoagulant (CP) on the growth and adhesion of MCF-7 cells to vitronectin in vitro
Cancer Lett.
222
89-94
2005
Homo sapiens
Manually annotated by BRENDA team
Jozwik, M.; Szajda, S.D.; Skrzydlewski, Z.; Jozwik, M.; Sulkowski, S.
The activity of cancer procoagulant in cases of uterine leiomyomas
Eur. J. Gynaecol. Oncol.
26
407-410
2005
Homo sapiens
Manually annotated by BRENDA team
Kamocka, M.; Kaplinska, K.; Mielicki, W.P.
Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats
Clin. Exp. Med.
6
119-123
2006
Homo sapiens
Manually annotated by BRENDA team
Szajda, S.D.; Jozwik, M.; Sulkowska, M.; Chabielska, E.; Sulkowski, S.; Jozwik, M.
Analysis of the relationship between cancer procoagulant activity and PCNA and Ki-67 expression in cases of common and cellular uterine leiomyomas
Eur. J. Gynaecol. Oncol.
27
495-499
2006
Homo sapiens
Manually annotated by BRENDA team
Kamocka, M.; Pollard, M.; Suckow, M.; Mielicki, W.P.; Rosen, E.D.
Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X
Comp. Med.
58
282-286
2008
Rattus norvegicus
Manually annotated by BRENDA team
Musallam, K.M.; Dahdaleh, F.S.; Shamseddine, A.I.; Taher, A.T.
Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy
Thromb. Res.
123
679-686
2009
Homo sapiens
Manually annotated by BRENDA team
Kaplinska, K.; Rozalski, M.; Krajewska, U.; Mielicki, W.P.
Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro
Thromb. Res.
124
364-367
2009
Homo sapiens
Manually annotated by BRENDA team
Kee, N.L.; Naude, R.J.; Blatch, G.L.; Frost, C.L.
The effect of cancer procoagulant on expression of metastatic and angiogenic markers in breast cancer and embryonic stem cell lines
Biol. Chem.
393
113-121
2012
Homo sapiens
Manually annotated by BRENDA team
Hoffman, E.A.; Gizelska, K.; Mirowski, M.; Mielicki, W.
Arsenic trioxide downregulates cancer procoagulant activity in MCF-7 and WM-115 cell lines in vitro
Contemp. Oncol. (Pozn.)
19
108-112
2015
Homo sapiens
Manually annotated by BRENDA team
Kee, N.L.; Krause, J.; Blatch, G.L.; Muramoto, K.; Sakka, K.; Sakka, M.; Naude, R.J.; Wagner, L.; Wolf, R.; Rahfeld, J.U.; Demuth, H.U.; Mielicki, W.P.; Frost, C.L.
The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation
Protein J.
34
338-348
2015
Homo sapiens
Manually annotated by BRENDA team
Krause, J.; Frost, C.L.
In vitro screening of synthetic fluorogenic substrates for detection of cancer procoagulant activity
Protein J.
37
151-163
2018
Rattus norvegicus
Manually annotated by BRENDA team